{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 8.714284, "regularMarketPrice": 0.6849, "exchange": "NCM", "shortName": "eFFECTOR Therapeutics, Inc.", "longName": "eFFECTOR Therapeutics, Inc.", "messageBoardId": "finmb_240590335", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": 0.093, "fiftyDayAverage": 0.42656, "fiftyDayAverageChange": 0.25833997, "fiftyDayAverageChangePercent": 0.6056357, "twoHundredDayAverage": 0.521765, "twoHundredDayAverageChange": 0.16313499, "twoHundredDayAverageChangePercent": 0.3126599, "marketCap": 29040582, "forwardPE": -0.74445647, "priceToBook": 7.364516, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.2 - Buy", "tradeable": false, "cryptoTradeable": false, "earningsTimestamp": 1683662463, "earningsTimestampStart": 1691405940, "earningsTimestampEnd": 1691755200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.64, "epsForward": -0.92, "epsCurrentYear": -0.85, "priceEpsCurrentYear": -0.8057647, "sharesOutstanding": 42401200, "firstTradeDateMilliseconds": 1614609000000, "priceHint": 4, "regularMarketChange": 0.05489999, "regularMarketTime": 1684180800, "regularMarketDayHigh": 0.7, "regularMarketDayRange": "0.64 - 0.7", "regularMarketDayLow": 0.64, "regularMarketVolume": 404418, "regularMarketPreviousClose": 0.63, "bid": 0.0, "ask": 0.0, "bidSize": 30, "askSize": 18, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 0.65, "averageDailyVolume3Month": 213075, "averageDailyVolume10Day": 263870, "fiftyTwoWeekLowChange": 0.3469, "fiftyTwoWeekLowChangePercent": 1.0263313, "fiftyTwoWeekRange": "0.338 - 2.97", "fiftyTwoWeekHighChange": -2.2851, "fiftyTwoWeekHighChangePercent": -0.7693939, "fiftyTwoWeekLow": 0.338, "fiftyTwoWeekHigh": 2.97, "marketState": "PRE", "displayName": "eFFECTOR Therapeutics", "symbol": "EFTR"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "142 North Cedros Avenue", "address2": "Suite B", "city": "Solana Beach", "state": "CA", "zip": "92075", "country": "United States", "phone": "858 925 8215", "website": "https://effector.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors and in combination with fulvestrant and abemaciclib in a Phase 2a open-label expansion cohort to treat patients with ER+ breast cancer. eFFECTOR Therapeutics, Inc. has a research collaboration and license agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Stephen T. Worland Ph.D.", "age": 64, "title": "CEO, Pres & Director", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 855255, "fmt": "855.25k", "longFmt": "855,255"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Byrnes M.B.A.", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2022, "totalPay": {"raw": 623690, "fmt": "623.69k", "longFmt": "623,690"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Douglas  Warner M.D.", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 304400, "fmt": "304.4k", "longFmt": "304,400"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Siegfried  Reich Ph.D.", "age": 62, "title": "Co-Founder and Member of Clinical & Scientific Advisory Board", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Davide  Ruggero Ph.D.", "title": "Co-Founder and Member of Clinical & Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kevan M. Shokat Ph.D.", "title": "Co-Founder and Member of Clinical & Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mayank J. Gandhi M.D.", "age": 44, "title": "Chief Bus. Officer", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}